VFA
Values First Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-579
| Closed | -$58.6K | – | 289 |
|
|
2023
Q1 | $58.6K | Buy |
+579
| New | +$58.6K | 0.04% | 183 |
|
|
2021
Q2 | – | Sell |
-2,433
| Closed | -$237K | – | 154 |
|
|
2021
Q1 | $237K | Buy |
2,433
+20
| +0.8% | +$1.95K | 0.17% | 129 |
|
|
2020
Q4 | $231K | Buy |
+2,413
| New | +$231K | 0.18% | 134 |
|
|
2020
Q3 | – | Sell |
-1,881
| Closed | -$230K | – | 144 |
|
|
2020
Q2 | $230K | Buy |
+1,881
| New | +$230K | 0.23% | 122 |
|
|
2020
Q1 | – | Sell |
-1,952
| Closed | -$210K | – | 138 |
|
|
2019
Q4 | $210K | Buy |
+1,952
| New | +$210K | 0.2% | 118 |
|